Interestingly, exposure to PGE2 before CM collection significantly augmented the ability of tissue sample A to increase the percentage of CD44+/CD24−/EpCAM+ cells (Fig. S3), suggesting that PGE2 enhanced fibroblast tumor promoting ability. The gene discussed is EPCAM; the disease is neoplasm.